查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1356675

血栓管理设备市场报告：2030 年趋势、预测与竞争分析

Clot Management Devices Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

血栓管理设备趋势与预测

到 2030 年，全球血栓管理设备市场预计将达到 25 亿美元，2024 年至 2030 年年复合成长率为 5.2%。该市场的主要促进因素是心血管疾病盛行率的上升和患病高龄化、对微创手术的意愿以及技术的不断进步。全球血栓管理设备市场前景广阔，诊断中心和医院市场存在商机。

血栓管理设备市场洞察

根据 Lucintel 的预测，神经血管栓塞装置预计将在预测期内实现最高增长，因为它们可用于治疗主要发生在脑血管中的栓塞等病变。

由于越来越多地采用院内专业部门、先进实验室和手术室进行心血管治疗，医院可能仍然是市场中最大的部分。

由于心血管疾病患病不断上升以及该地区医疗基础设施的改善，预计亚太地区在预测期内将出现最高的增长。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要要素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些，由于材料或产品替代导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球血栓管理设备市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业促进因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球血栓管理设备市场趋势（2018-2023）与预测（2024-2030）
  • 全球血栓管理设备市场（按产品）
    • 神经血管栓塞装置
    • 用于栓塞的球囊导管
    • 经皮栓装置
    • 导管定向溶栓（CDT）装置
    • 大静脉筛检程式(IVCF)
  • 按经经皮血栓切除设备类型分類的全球血栓管理设备市场
    • 抽吸血栓清除装置
    • 经皮机械取栓装置
  • 全球血栓管理设备市场（按最终用途）
    • 诊断中心
    • 医院
    • 其他的

第4章2018-2030年分地区市场趋势及预测分析

  • 全球血栓管理设备市场（按地区）
  • 北美血栓管理设备市场
  • 欧洲血栓管理设备市场
  • 亚太地区血栓管理设备市场
  • 其他区域血栓管理设备市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 全球血栓管理设备市场成长机会（按产品）
    • 按经皮血栓切除设备类型分類的全球血栓管理设备市场成长机会
    • 全球血栓管理设备市场成长机会（依最终用途）
    • 全球血栓管理设备市场成长机会（按地区）
  • 全球血栓管理设备市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 扩大全球血栓管理设备市场的产能
    • 全球血栓管理设备市场的合併、收购和合资企业
    • 认证和许可

第7章主要企业概况

  • Medtronic
  • Boston Scientific Corporation
  • iVascular SLU
  • Teleflex
  • Edwards Lifesciences Corporation
  • LeMaitre Vascular
  • Vascular Solutions
  • Straub Medical
  • Cook Medical
  • DePuy Synthes
简介目录

Clot Management Devices Trends and Forecast

The future of the global clot management devices market looks promising with opportunities in the diagnostic center and hospital markets. The global clot management devices market is expected to reach an estimated $2.5 billion by 2030 with a CAGR of 5.2% from 2024 to 2030. The major drivers for this market are rising prevalence of cardiovascular diseases and ageing population, increasing inclination towards minimally invasive surgeries and on-going advancements in technologies.

A more than 150-page report is developed to help in your business decisions.

Clot Management Devices by Segment

The study includes a forecast for the global clot management devices by product, percutaneous thrombectomy devices type, end use, and region.

Clot Management Devices Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Neurovascular Embolectomy Devices
  • Embolectomy Balloon Catheters
  • Percutaneous Thrombectomy Devices
  • Catheter-Directed Thrombolysis (CDT) Devices
  • Inferior Vena Cava Filters (IVCF)

Clot Management Devices Market by Percutaneous Thrombectomy Devices Type [Shipment Analysis by Value from 2018 to 2030]:

  • Aspiration Thrombectomy Devices
  • Percutaneous Mechanical Thrombectomy Devices

Clot Management Devices Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Diagnostic Centers
  • Hospitals
  • Others

Clot Management Devices Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Clot Management Devices Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies clot management devices companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the clot management devices companies profiled in this report include-

  • Medtronic
  • Boston Scientific Corporation
  • iVascular SLU
  • Teleflex
  • Edwards Lifesciences Corporation
  • LeMaitre Vascular
  • Vascular Solutions
  • Straub Medical
  • Cook Medical
  • DePuy Synthes

Clot Management Devices Market Insights

Lucintel forecasts that neurovascular embolectomy device is expected to witness highest growth over the forecast period because it helps in treating medical conditions like embolism, primarily occuring in brain bolld vessels.

Within this market, hospitals will remain the largest segment due to increasing adoption of specialized departments, advanced labs, and operating rooms in hospitals for cardiovascular treatments.

APAC is expected to witness highest growth over the forecast period due to increasing prevalence of cardiovascular diseases and improvement in the healthcare infrastructure in the region.

Features of the Global Clot Management Devices Market

Market Size Estimates: Clot management devices market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Clot management devices market size by product, percutaneous thrombectomy devices type, end use, and region. in terms of value ($B).

Regional Analysis: Clot management devices market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, percutaneous thrombectomy devices types, end uses, and region.s for the clot management devices market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the clot management devices market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the clot management devices market size?

Answer: The global clot management devices market is expected to reach an estimated $2.5 billion by 2030.

Q.2. What is the growth forecast for clot management devices market?

Answer: The global clot management devices market is expected to grow with a CAGR of 5.2% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the clot management devices market?

Answer: The major drivers for this market are rising prevalence of cardiovascular diseases and ageing population, increasing inclination towards minimally invasive surgeries and on-going advancements in technologies.

Q.4. What are the major segments for clot management devices market?

Answer: The future of the clot management devices market looks promising with opportunities in the diagnostic centers, and hospitals markets.future of the global clot management devices market looks promising with opportunities in the diagnostic center and hospital markets.

Q.5. Who are the key clot management devices market companies?

Answer: Some of the key clot management devices companies are as follows:

  • Medtronic
  • Boston Scientific Corporation
  • iVascular SLU
  • Teleflex
  • Edwards Lifesciences Corporation
  • LeMaitre Vascular
  • Vascular Solutions
  • Straub Medical
  • Cook Medical
  • DePuy Synthes

Q.6. Which clot management devices market segment will be the largest in future?

Answer: Lucintel forecasts that neurovascular embolectomy device is expected to witness highest growth over the forecast period because it helps in treating medical conditions like embolism, primarily occuring in brain bolld vessels.

Q.7. In clot management devices market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to increasing prevalence of cardiovascular diseases and improvement in the healthcare infrastructure in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the clot management devices market by product (neurovascular embolectomy devices, embolectomy balloon catheters, percutaneous thrombectomy devices,catheter-directed thrombolysis (CDT) devices, and inferior vena cava filters (IVCF)), percutaneous thrombectomy devices type (aspiration thrombectomy devices and percutaneous mechanical thrombectomy devices), end use (diagnostic centers, hospitals, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Clot Management Devices Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Clot Management Devices Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Clot Management Devices Market by Product
    • 3.3.1: Neurovascular Embolectomy Devices
    • 3.3.2: Embolectomy Balloon Catheters
    • 3.3.3: Percutaneous Thrombectomy Devices
    • 3.3.4: Catheter-Directed Thrombolysis (CDT) Devices
    • 3.3.5: Inferior Vena Cava Filters (IVCF)
  • 3.4: Global Clot Management Devices Market by Percutaneous Thrombectomy Devices Type
    • 3.4.1: Aspiration Thrombectomy Devices
    • 3.4.2: Percutaneous Mechanical Thrombectomy Devices
  • 3.5: Global Clot Management Devices Market by End Use
    • 3.5.1: Diagnostic Centers
    • 3.5.2: Hospitals
    • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Clot Management Devices Market by Region
  • 4.2: North American Clot Management Devices Market
    • 4.2.2: North American Clot Management Devices Market by End Use: Diagnostic Centers, Hospitals, and Others
  • 4.3: European Clot Management Devices Market
    • 4.3.1: European Clot Management Devices Market by Product: Neurovascular Embolectomy Devices, Embolectomy Balloon Catheters, Percutaneous Thrombectomy Devices,Catheter-Directed Thrombolysis (CDT) Devices, and Inferior Vena Cava Filters (IVCF)
    • 4.3.2: European Clot Management Devices Market by End Use: Diagnostic Centers, Hospitals, and Others
  • 4.4: APAC Clot Management Devices Market
    • 4.4.1: APAC Clot Management Devices Market by Product: Neurovascular Embolectomy Devices, Embolectomy Balloon Catheters, Percutaneous Thrombectomy Devices,Catheter-Directed Thrombolysis (CDT) Devices, and Inferior Vena Cava Filters (IVCF)
    • 4.4.2: APAC Clot Management Devices Market by End Use: Diagnostic Centers, Hospitals, and Others
  • 4.5: ROW Clot Management Devices Market
    • 4.5.1: ROW Clot Management Devices Market by Product: Neurovascular Embolectomy Devices, Embolectomy Balloon Catheters, Percutaneous Thrombectomy Devices,Catheter-Directed Thrombolysis (CDT) Devices, and Inferior Vena Cava Filters (IVCF)
    • 4.5.2: ROW Clot Management Devices Market by End Use: Diagnostic Centers, Hospitals, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Clot Management Devices Market by Product
    • 6.1.2: Growth Opportunities for the Global Clot Management Devices Market by Percutaneous Thrombectomy Devices Type
    • 6.1.3: Growth Opportunities for the Global Clot Management Devices Market by End Use
    • 6.1.4: Growth Opportunities for the Global Clot Management Devices Market by Region
  • 6.2: Emerging Trends in the Global Clot Management Devices Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Clot Management Devices Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Clot Management Devices Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Medtronic
  • 7.2: Boston Scientific Corporation
  • 7.3: iVascular SLU
  • 7.4: Teleflex
  • 7.5: Edwards Lifesciences Corporation
  • 7.6: LeMaitre Vascular
  • 7.7: Vascular Solutions
  • 7.8: Straub Medical
  • 7.9: Cook Medical
  • 7.10: DePuy Synthes